Related references
Note: Only part of the references are listed.The Human Papillomavirus E6 Oncoprotein Targets USP15 and TRIM25 To Suppress RIG-I-Mediated Innate Immune Signaling
Cindy Chiang et al.
JOURNAL OF VIROLOGY (2018)
The HPV E6/E7 Oncogenes: Key Factors for Viral Carcinogenesis and Therapeutic Targets
Karin Hoppe-Seyler et al.
TRENDS IN MICROBIOLOGY (2018)
Structural dynamics of the E6AP/UBE3A-E6-p53 enzyme-substrate complex
Carolin Sailer et al.
NATURE COMMUNICATIONS (2018)
USP15 inhibits HPV16 E6 degradation and catalytically inactive USP15 has reduced inhibitory activity
Y. Yaginuma et al.
ACTA VIROLOGICA (2018)
Worldwide burden of cancer attributable to HPV by site, country and HPV type
Catherine de Martel et al.
INTERNATIONAL JOURNAL OF CANCER (2017)
Structure of the E6/E6AP/p53 complex required for HPV-mediated degradation of p53
Denise Martinez-Zapien et al.
NATURE (2016)
Next generation prophylactic human papillomavirus vaccines
John T. Schiller et al.
LANCET ONCOLOGY (2015)
Role of ubiquitin and the HPV E6 oncoprotein in E6AP-mediated ubiquitination
Franziska Mortensen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Angelman syndrome-associated ubiquitin ligase UBE3A/E6AP mutants interfere with the proteolytic activity of the proteasome
V. Tomaic et al.
CELL DEATH & DISEASE (2015)
Human Viral Oncogenesis: A Cancer Hallmarks Analysis
Enrique A. Mesri et al.
CELL HOST & MICROBE (2014)
Structural Basis for Hijacking of Cellular LxxLL Motifs by Papillomavirus E6 Oncoproteins
Katia Zanier et al.
SCIENCE (2013)
Comprehensive Analysis of Host Cellular Interactions with Human Papillomavirus E6 Proteins Identifies New E6 Binding Partners and Reflects Viral Diversity
Elizabeth A. White et al.
JOURNAL OF VIROLOGY (2012)
Solution Structure Analysis of the HPV16 E6 Oncoprotein Reveals a Self-Association Mechanism Required for E6-Mediated Degradation of p53
Katia Zanier et al.
STRUCTURE (2012)
Human papillomavirus oncoproteins: pathways to transformation
Cary A. Moody et al.
NATURE REVIEWS CANCER (2010)
Ubiquitination, Ubiquitin-like Modifiers, and Deubiquitination in Viral Infection
Marisa K. Isaacson et al.
CELL HOST & MICROBE (2009)
A novel peptide motif binding to and blocking the intracellular activity of the human papillomavirus E6 oncoprotein
Susanne Dymalla et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2009)
The Ubiquitin-Specific Peptidase USP15 Regulates Human Papillomavirus Type 16 E6 Protein Stability
Robin M. Vos et al.
JOURNAL OF VIROLOGY (2009)
The stability of the human papillomavirus E6 oncoprotein is E6AP dependent
Vjekoslav Tomaic et al.
VIROLOGY (2009)
Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology:: a meta-analysis
Silvia de Sanjose et al.
LANCET INFECTIOUS DISEASES (2007)
Transcriptional inhibition of the human papilloma virus reactivates tumor suppressor p53 in cervical carcinoma cells
D. V. Kochetkov et al.
MOLECULAR BIOLOGY (2007)
Epigenetic overlap in autism-spectrum neurodevelopmental disorders:: MECP2 deficiency causes reduced expression of UBE3A and GABRB3
RC Samaco et al.
HUMAN MOLECULAR GENETICS (2005)
Ubiquitination and proteasome degradation of the E6 proteins of human papillomavirus types 11 and 18
D Stewart et al.
JOURNAL OF GENERAL VIROLOGY (2004)
Endogenous human papillomavirus E6 and E7 proteins differentially regulate proliferation, senescence, and apoptosis in HeLa cervical carcinoma cells
RA DeFilippis et al.
JOURNAL OF VIROLOGY (2003)
Selective silencing of viral gene expression in HPV-positive human cervical carcinoma cells treated with siRNA, a primer of RNA interference
M Jiang et al.
ONCOGENE (2002)
Cellular steady-state levels of high risk but not low risk human papillomavirus (HPV) E6 proteins are increased by inhibition of proteasome-dependent degradation independent of their p53-and E6AP-binding capabilities
E Kehmeier et al.
VIROLOGY (2002)
Regulation of the G2/M transition by p53
WR Taylor et al.
ONCOGENE (2001)
Repression of human papillomavirus oncogenes in HeLa cervical carcinoma cells causes the orderly reactivation of dormant tumor suppressor pathways
EC Goodwin et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Activation of p53 in cervical carcinoma cells by small molecules
S Hietanen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Human papillomavirus types 16 E6 and E7 contribute differently to carcinogenesis
S Song et al.
VIROLOGY (2000)
Share Paper
